Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100 shares at $1056.81 ($106K) on 2024-07-01, disclosed to the SEC on 2024-07-02.
Scheduled sale ($106k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1047.11 | 3 | $3K | 3.0% |
| 2 | $1050.87 | 2 | $2K | 2.0% |
| 3 | $1051.58 | 7 | $7K | 6.9% |
| 4 | $1052.19 | 6 | $6K | 6.0% |
| 5 | $1053.60 | 8 | $8K | 8.0% |
| 6 | $1054.25 | 1 |
| $1K |
| 1.0% |
| 7 | $1056.81 | 2 | $2K | 2.0% |
| 8 | $1057.64 | 2 | $2K | 2.0% |
| 9 | $1058.49 | 17 | $18K | 17.0% |
| 10 | $1059.36 | 3 | $3K | 3.0% |
| 11 | $1060.14 | 3 | $3K | 3.0% |
| 12 | $1061.73 | 3 | $3K | 3.0% |
| 13 | $1062.31 | 19 | $20K | 19.1% |
| 14 | $1063.87 | 5 | $5K | 5.0% |
| 15 | $1064.55 | 7 | $7K | 7.0% |
| 16 | $1065.52 | 3 | $3K | 3.0% |
| 17 | $1066.59 | 4 | $4K | 4.0% |
| 18 | $1067.51 | 3 | $3K | 3.0% |
| 19 | $1068.09 | 2 | $2K | 2.0% |
| Total | $1059.24 avg | 100 | $106K | 100% |
| Filing → |
| REGN | SELL | 2026-04-03 | $78K | — | Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |